
About company
Intersect Diagnostics is a life science research and development laboratory that focuses on developing proprietary assays with the use of the high-parameter spatial discovery technologies and data analytics to advance the biomarker discovery for precision therapeutics. The company delivers services for its biotech and biopharma partners by designing and validating customized, bespoke assays that incorporate both well-known and novel, relatively understudied biomarkers. It deploys these assays in their own, Good Clinical Practice (GCP), a compliant laboratory operating under a robust Quality Management program designed to pass rigorous audits and inspections. Boaz Kurtis founded it in 2019 and established in Ridgewood, New Jersey.